GLPwatch
Papers (10389)
Page 155 of 174, ranked by citation count.
- Novel finding of pulmonary embolism following tirzepatide (Manjaro) use in a young adult without risk factors of venous thromboembolic events.
- Structure-aware fragment assignment for interpreting tandem mass spectrometry of modified and cyclic peptides.
- Pharmacological therapy in the obese patient: is it only a matter of fat loss?
- Glucagon-like peptide-1 receptor agonists in individuals with severe mental illness: A systematic review and meta-analysis of randomized controlled trials.
- Long-Term Effects of Semaglutide and Sitagliptin on Circulating IGFBP-1, IGFBP-3 and IGFBP-rp1: Results from a One-Year Study in Type 2 Diabetes.
- Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART Trial.
- Community Pharmacists' Knowledge and Counseling Competence on GLP-1 Receptor Agonists in Obesity and Type 2 Diabetes Care in Türkiye: A Cross-Sectional Study.
- [Beta-cell function in the foreground. GLP-1 based therapy of type 2 diabetes].
- Medications for Obstructive Sleep Apnea.
- Semaglutide for Weight Loss: Was It Worth the Weight?: Erratum.
- Design of biomimetic chylomicrons based on 1,3-diolein grafted hyaluronic acid to drive biomacromolecules across the intestinal mucosal barrier.
- [Weight reducing and glucose reducing effects of liraglutide treatment for patients with type 2 diabetes].
- A Relative Cost of Control Analysis of IDegLira versus Other Forms of Basal Insulin Intensification in Mexico.
- Impact of semaglutide pretreatment on reproductive outcomes in women with overweight and obesity with infertility: a real-world multicenter cohort study.
- Acute Contractile Effects of Glucagon-like-Peptide-1 Receptor Agonists in the Human Heart.
- [Does liraglutide have a place in psychiatry ?]
- [Effect of liraglutide in treatment of non-alcoholic fatty liver disease: mechanism of action and research advances].
- Effect of Adherence to Oral Semaglutide on Glycemic Control in People With Type 2 Diabetes Treated With Metformin: Protocol for an Open-Label Clinical Trial.
- Association Between Early Weight Loss and Metabolic Outcomes with Tirzepatide in Japanese Patients with Type 2 Diabetes: A SURPASS J Post Hoc Analysis.
- MASH and liver fibrosis: Clinical trials to watch.
- Lixisenatide clinical experience on patients with type 2 diabetes and obesity in endocrinology offices in Malaga.
- The impact of oral semaglutide on cardiovascular events in patients with type 2 diabetes: review of results from the SOUL trial.
- Liraglutide enhances bone regeneration in a critical-size calvarial defect model in male rats: A comparative study with autogenous grafts, allografts, and xenografts.
- ARPA-H bets big to foster drugs that thwart aging.
- Starvation ketoacidosis associated with tirzepatide use for weight loss in a non-diabetic East Asian woman: a case report.
- Real-World Effectiveness and 12-Month Persistence of a Semaglutide-Supported Digital Weight-Loss Service: A Retrospective Cohort Study in Germany.
- A Systematic Review and Meta-Analysis of Semaglutide Effects on Adipose Tissue and Emerging Effects on Brain and Cognition.
- 18 F-FDG PET/CT Five Days Post First Administration of Semaglutide : Side Effects in One Shot.
- Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined. Reply.
- Effect of oral semaglutide on cardiometabolic risk factors in overweight and obese individuals with or without diabetes: a systematic review and meta-analysis.
- [ANMCO Statement: semaglutide in cardio-nephro-metabolic disorders].
- [Impact of Elon Musk's statements on the use of semaglutide in the Lazio Region: a time series analysis study.]
- Semaglutide attenuates diabetic vascular calcification by enhancing autophagy and lysosomal function via targeting CPNE1.
- Atypical Antipsychotics-Induced Glucose and Lipid Metabolism Disorders and Therapeutic Intervention.
- Ocular complications from glucagon-like peptide-1 receptor agonists: Clinical evidence, potential mechanisms, and clinical recommendations.
- Addressing the obesity challenge in plastic surgery - the role of liraglutide.
- Acute Deep Vein Thrombosis in the Setting of Tirzepatide Use: A Case Highlighting Emerging Concerns.
- Mazdutide 9 mg in Chinese adults with a body mass index ≥30 kg/m<sup>2</sup> but without diabetes: A phase 2 randomized controlled trial.
- Ozempic and dental therapy.
- Development and validation of an LC-MS/MS method for Tirzepatide, a dual GIP/GLP-1 receptor agonist, in rat plasma for application to a pharmacokinetic study.
- Implications of Glucagon-Like Peptide-1 Receptor Agonists in Otolaryngology - Head and Neck Surgery: A Review.
- Pharmacological Management of Diabesity: Current and Emerging Therapies.
- Liraglutide Modulates Zinc Release and Improves Mitochondrial Function in Insulin-Resistant Senescent Cardiomyocytes.
- Design and fabrication of a mesoporous silica scaffold for oral delivery of peptides.
- Medication Adherence in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
- [Among adults with cardiovascular disease and BMI≥27kg/m<sup>2</sup> but no diabetes, does semaglutide lower risk of cardiovascular mortality, myocardial infarction, or stroke when compared with placebo, and is it safe?]
- [Cardiovascular Effects of Antidiabetic Therapies].
- Mental health outcomes in obesity interventions with GLP-1 receptor agonists: is it similar to other obesity interventions? A narrative review with systematic evidence synthesis.
- Comparative effects of lifestyle modification, metformin and exenatide/glargine combination therapy on daily glycaemic fluctuation in the setting of near-normoglycaemia.
- The evidence for oral semaglutide in type 2 diabetes from a managed care perspective.
- SEMASEARCH Study Design: Real-World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials.
- Exenatide through PPARδ improved hepatic insulin resistance in patients of type 2 diabetes mellitus via suppressing pyroptosis.
- Comparison of Semaglutide and Lifestyle Counselling for Weight Loss Using Multi-Site Electronic Health Records.
- Orforglipron and the emergence of oral GLP-1 therapy for obesity: efficacy, safety, and clinical positioning.
- Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.
- Semaglutide Protects Retinal Ganglion Cells Against Rotenone-Induced Degeneration via Improved Glucose Metabolism.
- Resistant and Refractory Obesity: The Complexity of Anti-Obesity Therapy Failure.
- Antidiabetikum vor neuer Karriere.
- [Therapeutic use and adverse events of incretin-related drugs].
- Semaglutide and Effort-Based Decision-Making in Major Depressive Disorder: A Randomized Clinical Trial.